In contrast, an in vivo study suggested that blood monocytes promote tumor growth by differentiating into tolerogenic dendritic cells (DCs) that produce interleukin-10 (IL-10) and potently induce regulatory T cell responses (30). This evidence concerns the gene IL10 and neoplasm.